Sanner appoints new CEO to drive CDMO strategy
Ella Day | August 11, 2025 | Appointment | Contract Manufacturing, Manufacturing and Production | CEO, Corporate, Sanner, contract development and manufacturing organisation
German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development and manufacturing organisation (CDMO) for medical devices and complex pharma drug delivery systems.
Current CEO Johannis Willem van Vliet will step down, having led major strategic moves including the acquisitions of Springboard and Gilero and the launch of new production sites in Bensheim, Germany and Greensboro, US. “Johannis has taken decisive steps to position the Sanner Group as a global medtech and pharma supplier,” said interim CEO Heino Lennartz.
Lennartz, who currently serves as chairman, will assume the interim CEO role until autumn 2025, using his CDMO and pharma expertise to support the transition.
Stefan Verheyden, a chemist with more than 30 years’ experience in the pharma, biopharma and primary packaging industries, will take over as CEO. He was most recently global vice president sales pharma and biopharma injectables at a leading sector company, bringing rich market insight.
“We are delighted to welcome Verheyden to the Sanner Group as an experienced CEO. His many years of expertise and reputation in the industry will be a great asset to us in both the packaging and CDMO sectors,” Lennartz added.
Founded in 1894, Sanner now supplies products to more than 150 countries, with facilities in Germany, France, Hungary, China and the US.
Ella Day
11/8/25
Related Content
ESTEVE expands into US market with acquisition of Regis Technologies
ESTEVE (Esteve Química), based in Barcelona, Spain, has acquired Regis Technologies, a contract development and …
Ascend granted certification for quality control testing at Munich facility
Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received …
CEO of PixarBio Corporation sentenced to prison for defrauding investors
Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in …
